Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Marth

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Digestive Diseases (Basel, Switzerland)|November 10, 2009
New insights into Whipple's disease - a rare intestinal inflammatory disorderThomas Marth
Medizinische Klinik (Munich, Germany : 1983)|December 16, 2006
[Bizarre gastrointestinal bridges: segmental bridging polyps in the colon]Thomas Marth
World Journal of Cardiology|December 31, 2014
Complicated Whipple's disease and endocarditis following tumor necrosis factor inhibitorsThomas Marth
Digestive Diseases (Basel, Switzerland)|May 1, 2015
Tropheryma whipplei , Immunosuppression and Whipple's Disease: From a Low-Pathogenic, Environmental Infectious Organism to a Rare, Multifaceted Inflammatory ComplexThomas Marth
Acta Clinica Belgica|November 26, 2016
Whipple's diseaseThomas Marth
Current Opinion in Gastroenterology|February 28, 2008
Whipple diseaseThomas Marth, Thomas Schneider
Lancet (London, England)|January 28, 2003
Whipple's diseaseThomas Marth, Didier Raoult
International Journal of Medical Microbiology : IJMM|May 21, 2003
Mucosal immune response to Tropheryma whippleiSabine Ring, Thomas Schneider, Thomas Marth
Gastroenterology|November 3, 2009
Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's diseaseGerhard E Feurle, Natascha S Junga, Thomas Marth
European Journal of Radiology|July 30, 2025
Gadolinium concentration dependent signal enhancement profiles using routine clinical sequences with gadopiclenol, gadoterate, gadobutrol, and gadoxetate at 1.5, 3 and 7 TeslaThomas Marth, Johannes M Froehlich, Daniel Nanz, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Digestive Diseases (Basel, Switzerland)|November 10, 2009
New insights into Whipple's disease - a rare intestinal inflammatory disorderThomas Marth
Medizinische Klinik (Munich, Germany : 1983)|December 16, 2006
[Bizarre gastrointestinal bridges: segmental bridging polyps in the colon]Thomas Marth
World Journal of Cardiology|December 31, 2014
Complicated Whipple's disease and endocarditis following tumor necrosis factor inhibitorsThomas Marth
Digestive Diseases (Basel, Switzerland)|May 1, 2015
Tropheryma whipplei , Immunosuppression and Whipple's Disease: From a Low-Pathogenic, Environmental Infectious Organism to a Rare, Multifaceted Inflammatory ComplexThomas Marth
Acta Clinica Belgica|November 26, 2016
Whipple's diseaseThomas Marth
Current Opinion in Gastroenterology|February 28, 2008
Whipple diseaseThomas Marth, Thomas Schneider
Lancet (London, England)|January 28, 2003
Whipple's diseaseThomas Marth, Didier Raoult
International Journal of Medical Microbiology : IJMM|May 21, 2003
Mucosal immune response to Tropheryma whippleiSabine Ring, Thomas Schneider, Thomas Marth
Gastroenterology|November 3, 2009
Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's diseaseGerhard E Feurle, Natascha S Junga, Thomas Marth
European Journal of Radiology|July 30, 2025
Gadolinium concentration dependent signal enhancement profiles using routine clinical sequences with gadopiclenol, gadoterate, gadobutrol, and gadoxetate at 1.5, 3 and 7 TeslaThomas Marth, Johannes M Froehlich, Daniel Nanz, et al.
Pageof 4